Mary Kay Ash Foundation ® Gifts $500,000 Grant to Advance Cancer Research and Early Detection at Baylor Scott & White Health
13.11.2025 14:01:00 CET | Business Wire | Press Release
The Mary Kay Ash Foundation®, a champion of women’s health innovation for nearly three decades, announced a $500,000 grant to Baylor Scott & White Dallas Foundation to accelerate a pioneering triple-negative breast cancer clinical trial and advance early detection initiatives that shift care from reactive to proactive at the newly established Texas Cancer Interception Institute.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251113339900/en/
In recognition of its steadfast, decades-long commitment to women’s health, the Mary Kay Ash Foundation was honored with the prestigious Circle of Care Award at the 2025 Celebrating Women Luncheon, hosted by the Baylor Scott & White Dallas Foundation. The award celebrates those who have made a profound impact in shaping the future of breast cancer care through advocacy, philanthropy, and innovation. Since its inception, the luncheon has raised more than $42 million to fund research, advance detection, and support programs that empower women and families facing breast cancer. Photo Credit: Kristina Bowman
The two-fold grant includes:
- $100,000 in continued support of a forward-thinking TRIM-EBC Clinical Trial led by world renowned Celebrating Women chair for Breast Cancer Research, Joyce O’Shaughnessy, MD. The trial explores the potential of weight-loss medications to reduce recurrence risk in overweight breast cancer patients.
- The second part is a multi-year gift to the Texas Cancer Interception Institute, which aims to detect and intercept cancer at its earliest stages – when it is most treatable, will help shift women’s cancer narratives from “I have cancer,” to “I have cancer, but we caught it early.” Designed to be deployed on a broad scale, the program aims to revolutionize early detection and intervention strategies for better breast cancer survivorship and beyond.
This latest commitment underscores a shared mission between the two organizations: to invest in transformative cancer research that improves outcomes and brings us closer to curing cancers that disproportionately affect women. Over the past two decades, the Mary Kay Ash Foundation® has contributed $1.3 million to the Baylor Scott & White Dallas Foundation, reflecting an enduring alliance rooted in scientific discovery and compassion.
“The Mary Kay Ash Foundation remains committed to finding cures for cancers affecting women – we are championing for our mothers, daughters, sisters, and all the women in our lives,” said Michael Lunceford, President, Mary Kay Ash Foundation Board of Directors. “This grant represents a powerful next step in redefining cancer care – moving from a reactive nature to early detection and viable treatment options – with the goal of a long, healthy life after cancer. We are honored to stand alongside Baylor Scott & White in shaping the future of women’s health.”
In recognition of its steadfast, decades-long commitment to women’s health, the Mary Kay Ash Foundation was honored with the prestigious Circle of Care Award at the 2025 Celebrating Women Luncheon, hosted by the Baylor Scott & White Dallas Foundation. The award celebrates those who have made a profound impact in shaping the future of breast cancer care through advocacy, philanthropy, and innovation. Since its inception, the luncheon has raised more than $42 million to fund research, advance detection, and support programs that empower women and families facing breast cancer.
“Mary Kay Ash believed in the power of women to change the world – that conviction lives on through her namesake Foundation’s bold commitment to advancing women’s health by investing in early detection and better treatments,” said Christina Goodman, President, Baylor Scott & White Dallas Foundation. “When brilliant minds like Dr. Joyce O’Shaughnessy, MD and compassionate hearts come together, extraordinary things happen. This partnership is focused on bringing hope, healing, and new possibilities to patients and families across our communities.”
Did You Know?
Mary Kay is committed to ending cancers affecting women globally with its impact extending around the world through research funding and awareness campaigns driven by Mary Kay markets on multiple continents:
- In Spain, Mary Kay partners with the FERO Foundation to support metastatic breast cancer research.
- In Brazil, the Instituto Mary Kay funds cancer education and screening programs reaching thousands of women annually.
- In Malaysia, Mary Kay collaborates with the National Cancer Society of Malaysia to promote early detection.
- In Canada, the Mary Kay Ash Charitable Foundation supports Look Good Feel Better® workshops for women undergoing cancer treatment and provides product donations to help women feel beautiful after cancer.
Together, Mary Kay Inc., its global markets, and its four company-sponsored foundations and charitable funds have contributed nearly $44 million worldwide to help eliminate cancers affecting women. Learn more about Mary Kay’s ongoing global impact – from advancing women’s health and empowerment to protecting natural resources and fostering lasting change – in the 2025 Sustainability Report.
About Mary Kay Ash Foundation®
Guided by Mary Kay Ash’s dream to enrich the lives of women everywhere, the Mary Kay Ash Foundation® raises and distributes funds to end domestic violence and invest in breakthrough cancer research to find cures for women-related cancers. Since 1996, the Mary Kay Ash Foundation has contributed more than $98 million to organizations aligned with its two-fold mission. In addition, the Foundation supports awareness initiatives, community outreach programs, and advocates for legislation to ensure women are healthy and safe. Together, we can make the world better for women. To learn more about how to educate, advocate, volunteer, donate, and join life-saving work to support and empower women, visit marykayashfoundation.org, or find us on Facebook and Instagram.
About Baylor Scott & White Dallas Foundation
Baylor Scott & White Dallas Foundation raises money to advance the Mission of Baylor Scott & White Health: Founded as a Christian ministry of healing, Baylor Scott & White Health promotes the well-being of all individuals, families and communities. At Baylor Scott & White Dallas Foundation, philanthropy is the catalyst for change – advancing innovation, expanding access to compassionate care and empowering more people to live well. Together, we are shaping the future of healthcare in North Texas.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251113339900/en/
Contacts
Mary Kay Ash Foundation®
Newsroom.marykay.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2FNewsroom.maryka
y.com&esheet=54357189&newsitemid=20251113339900&lan=en-US&anchor=Newsroom.maryka
y.com&index=14&md5=240c9ba538b2a08d61110bbf6901135c
info@marykayashfoundation.org
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press Release
Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide. Relfydess is the first and only ready-to-use liquid neuromodulator developed with PEARL Technology, designed to deliver a highly active, innovative, complex-free molecule that addresses the real needs of patients and healthcare professionals.1,2,4,5 It is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.1,10 At a time whenpatients and healthcare professionals are increasingly seeking high-performance neuromodulators that rapidly deliver long-lasting, natural-looking outcomes, Re
Mundipharma Announces Further Phase III ReSPECT Results Presented as a Late-Breaking Oral Presentation at IDWeek 202622.10.2026 19:03:00 CEST | Press Release
Today Mundipharma announced additional results from the global Phase III ReSPECT clinical trial evaluating REZZAYO®(rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT). The Phase III findings were presented today as a late-breaking oral presentation at IDWeek 2026. The presentation provides additional detail following the top line ReSPECT results announced in April 2026, including further endpoint analyses, the components contributing to fungal-free survival (FFS), pre-specified sensitivity analyses and detailed safety outcomes. The additional analyses were consistent with the previously announced topline findings. ReSPECT was a global, multicentre, randomised, double-blind Phase III study in which 402 patients were randomised to rezafungin and 200 to the standard antimicrobial regimen. As previously announced, the study met its primary endpoint, demonstrating non-inferiority
Tigo Energy Improves Installer Choice via Fronius Compatibility with TS4 Product Line22.10.2026 18:02:00 CEST | Press Release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced a manufacturer declaration of compatibility from Fronius International GmbH, documenting compatibility between Tigo Flex MLPE products and multiple Fronius inverter families. The letter covers Tigo TS4-A-F, TS4-A-2F, TS4-A-O, and TS4-X-O products and the Fronius Primo GEN24, Primo GEN24 208-240, Symo GEN24, Verto, Tauro, and Tauro ECO inverter families, when configured according to the requirements specified by Fronius and Tigo. Building on established compatibility in Europe, the declaration extends manufacturer-confirmed compatibility to markets worldwide, including the United States and Canada, giving solar professionals greater flexibility to design high-quality systems using manufacturer-confirmed technology combinations. Fronius develops solar technologies and solutions for residential, commercial, and large-scale applications, with a port
Saudi Maritime & Logistics Congress Highlights Maritime Sector Integration and Opportunities for Trade and Investment Growth in the Kingdom22.10.2026 16:52:00 CEST | Press Release
The Saudi Maritime & Logistics Congress highlighted Saudi Arabia’s role in supporting the continuity of trade flows and strengthening supply chain resilience as it opened at Jeddah Superdome, bringing together representatives of government entities, maritime transport and logistics leaders, and the business community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022362613/en/ The Congress takes place as rapid changes in trade and shipping prompt companies to reassess transport routes and operational and investment choices. It provides a platform for dialogue among stakeholders to explore opportunities for cooperation and strengthen integration between ports and maritime, land transport and logistics services, supporting operational efficiency and supply chain reliability. In his opening address, His Excellency Eng. Fawaz Alsahli, President of the Transport General Authority in Saudi Arabia, emphasised that the Kingdom’s
Ministerial Roundtable Discusses Mobilising Green Investments for a Resilient and Inclusive Global Economy22.10.2026 16:49:00 CEST | Press Release
HE Saeed Mohammed Al Tayer, Chairman of the World Green Economy Organization, opened the Ministerial Roundtable titled "From Ambition to Bankable Action-Mobilising Green Investments for a Resilient and Inclusive Global Economy," during the 12th World Green Economy Summit (WGES), held on 21-22 October 2026 at the Dubai World Trade Centre under the theme "From Success to Scale: Showcasing the Green Economy." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022803264/en/ Ministerial Roundtable Discusses Mobilising Green Investments for a Resilient and Inclusive Global Economy (Photo: AETOSWire) The session was attended by HE Dr. Amna bint Abdullah Al Dahak, Minister of Climate Change and Environment, the United Arab Emirates; HE Aliou Gori Diouf, Minister of Environment and Ecological Transition, Senegal; HE Balarabe Abbas Lawal, Minister of Environment, Nigeria; HE Steven Victor, Minister of Agriculture, Fisheries, and the En
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom